525 results on '"Berg, Tobias"'
Search Results
2. If managers feel safe, budget control becomes enabling. Evidence from a large local government organization in Sweden
3. The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy
4. High inter-laboratory variability in the assessment of HER2-low breast cancer: a national registry study on 50,714 Danish patients
5. Identification of cells of leukemic stem cell origin with non-canonical regenerative properties
6. The average professional
7. On the role and effects of supervisor feedback sign in auditing: Evidence from a cohort of early career auditors.
8. Real-world effectiveness of CDK 4/6 inhibitors in estrogen-positive metastatic breast cancer
9. Abstracts of the Cell Therapy Transplant Canada 2023 Annual Conference
10. Incidence and survival of primary metastatic breast cancer in Denmark; implication of breast cancer screening, classification, and staging practice
11. Figure S3 from Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer
12. Table S3 from Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer
13. Data from Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer
14. Ergodic branching diffusions with immigration: properties of invariant occupation measure, identification of particles under high-frequency observation, and estimation of the diffusion coefficient at nonparametric rates
15. Medical treatment of advanced breast cancer
16. Development and Methodological Validation of a Modified Staging System for de Novo Metastatic Breast Cancer
17. Prognostic Value of Pre-treatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer
18. GFI1 is required for RUNX1/ETO positive acute myeloid leukemia
19. Epigenetic maintenance strategies after allogeneic stem cell transplantation in acute myeloid leukemia
20. Credit Supply Shocks: Financing Real Growth or Takeovers?
21. Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer.
22. Dose modifications of ribociclib and endocrine therapy for treatment of ER+ HER2− metastatic breast cancer
23. Spillover effects in empirical corporate finance
24. Do Voluntary Pledges Make Loans Greener?
25. The successful management of acute promyelocytic leukemia during pregnancy: a case report
26. LSD1 Inhibition Enhances Antigen Presentation and Co-Stimulation in AML to Promote T Cell-Mediated Anti-Leukemia Immune Responses
27. On the Rise of FinTechs : Credit Scoring Using Digital Footprints
28. Brexit and the contraction of syndicated lending
29. Neoadjuvant chemotherapy and HER2 dual blockade including biosimilar trastuzumab (SB3) for HER2-positive early breast cancer: Population based real world data from the Danish Breast Cancer Group (DBCG)
30. The successful management of acute promyelocytic leukemia during pregnancy: a case report.
31. Dual HER2 blockade in the first-line treatment of metastatic breast cancer - A retrospective population-based observational study in Danish patients
32. Treating brain metastases in metastatic breast cancer: outcomes after stereotactic radiosurgery examined in a retrospective, single-center cohort analysis
33. Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non‐small cell lung cancer (NSCLC) through inhibition of HIF‐1α
34. Got Rejected? Real Effects of Not Getting a Loan
35. Gemcitabine for recurrent ovarian cancer - a systematic review and meta-analysis
36. On the diffusion and implementation of trust-based management in Scandinavia: cross-country survey evidence.
37. Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation
38. Real-world survival of Danish patients with HER2-positive metastatic breast cancer
39. Implementation of Gender and Diversity Perspectives in Transport Development Plans in Germany
40. What Explains the Difference in Leverage between Banks and Nonbanks?
41. FinTech Lending
42. Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation
43. LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML
44. Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties
45. Mind the Gap: The Difference between U.S. and European Loan Rates
46. Identifying recurrent breast cancer patients in national health registries using machine learning
47. A nationwide observational study in heavily pretreated metastatic HER2-positive breast cancer patients
48. LSD1 inhibition modulates transcription factor networks in myeloid malignancies
49. A retrospective, non-interventional study of breast cancer patients diagnosed with ER+/HER2 negative, locally advanced or metastatic breast cancer treated with palbociclib in Denmark
50. An analysis of the consistency of banks’ internal ratings
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.